Medi Pharma Innovation Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 30.56%
- Ebitda -30.21%
- Net Worth -20.25%
- Total Assets 85.32%
About Medi Pharma Innovation
Medi Pharma Innovation Private Limited (MPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 2020 (Four years and five months 19 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Joydeb Bhattacharjee, Koushik Jana, and Nabanita Sarkar serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36999WB2020PTC239072
-
Company No.
239072
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Aug 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Medi Pharma Innovation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Joydeb Bhattacharjee
|
Director | 22-Aug-2020 | Current |
|
Koushik Jana
|
Director | 22-Aug-2020 | Current |
|
Nabanita Sarkar
|
Director | 22-Aug-2020 | Current |
Financial Performance of Medi Pharma Innovation.
Medi Pharma Innovation Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.56% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Pharma Innovation?
Unlock access to Medi Pharma Innovation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medi Pharma Innovation?
Unlock and access historical data on people associated with Medi Pharma Innovation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Pharma Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Pharma Innovation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.